
NVOx is a tokenised tracker certificate issued on Solana SPL and ERC-20 standards. It mirrors the price of Novo Nordisk A/S shares, offering eligible users a blockchain-based method of accessing exposure to this underlying equity.
Novo Nordisk A/S is a Danish healthcare company focused on chronic diseases such as diabetes, obesity, and rare and cardiovascular conditions. The company operates globally with a strong emphasis on scientific research, therapeutic access, and disease prevention.